Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
All voices matter
oncology
Harvard AI model predicts which cancer patients will respond to immunotherapy
Researchers at Harvard Medical School have developed an artificial intelligence model called COMPASS that can predict which cancer patients will respond to immune checkpoint inhibitors, a class of drugs that works in only a fraction of those who receive them.…
New CAR-T therapy shows early success against solid tumors
Researchers at the University of Calgary's Charbonneau Cancer Institute and McMaster University have developed GCAR1, a first-in-class chimeric antigen receptor T-cell therapy designed to attack solid tumors — a category of cancer that has largely resisted the immunotherapy approach until…